Literature DB >> 23666270

Environment-related adaptive changes of gut commensal microbiota do not alter colonic toll-like receptors but modulate the local expression of sensory-related systems in rats.

M Aguilera1, P Vergara, V Martínez.   

Abstract

Pathogenic and protective roles have been attributed to gut commensal microbiota (GCM) in gastrointestinal inflammatory and functional disorders. We have shown that the adaptation to a new environment implies specific changes in the composition of GCM. Here we assessed if environment-related adaptive changes of GCM modulate the expression of colonic Toll-like receptors (TLRs) and sensory-related systems in rats. Adult male SD rats were maintained under different environmental conditions: barrier-breed-and-maintained, barrier-breed adapted to conventional conditions or conventional-breed-and-maintained. Fluorescent in situ hybridization and real-time quantitative PCR (qPCR) were used to characterize luminal ceco-colonic microbiota. Colonic expression of TLR2, TLR4, TLR5, and TLR7, cannabinoid receptors (CB1/CB2), μ-opioid receptor (MOR), transient receptor potential vanilloid (TRPV1, TRPV3, and TRPV4), protease-activated receptor 2 (PAR-2), and calcitonin gene-related peptide were quantified by RT-qPCR. CB1, CB2 and MOR expression, was evaluated also by immunohistochemistry. In rats, housing-related environmental conditions induce specific changes of GCM, without impact on the expression of TLR-dependent bacterial recognition systems. Expression of sensory-related markers (MOR, TRPV3, PAR-2, and CB2) decreased with the adaptation to a conventional environment, correlating with changes in Bacteroides spp., Lactobacillus spp., and Bifidobacterium spp. counts. This suggests an interaction between GCM and visceral sensory mechanisms, which might be part of the mechanisms underlying the beneficial effects of some bacterial groups on functional and inflammatory gastrointestinal disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23666270     DOI: 10.1007/s00248-013-0241-0

Source DB:  PubMed          Journal:  Microb Ecol        ISSN: 0095-3628            Impact factor:   4.552


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Extensive set of 16S rRNA-based probes for detection of bacteria in human feces.

Authors:  Hermie J M Harmsen; Gerwin C Raangs; Tao He; John E Degener; Gjalt W Welling
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

Review 3.  Expression and functional importance of innate immune receptors by intestinal epithelial cells.

Authors:  Rute Marques; Ivo G Boneca
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

4.  A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial.

Authors:  Yu-jing Fan; Shu-jie Chen; Ying-cong Yu; Jian-min Si; Bin Liu
Journal:  J Zhejiang Univ Sci B       Date:  2006-12       Impact factor: 3.066

5.  Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.

Authors:  Christel Rousseaux; Xavier Thuru; Agathe Gelot; Nicolas Barnich; Christel Neut; Laurent Dubuquoy; Caroline Dubuquoy; Emilie Merour; Karen Geboes; Mathias Chamaillard; Arthur Ouwehand; Greg Leyer; Didier Carcano; Jean-Frédéric Colombel; Denis Ardid; Pierre Desreumaux
Journal:  Nat Med       Date:  2006-12-10       Impact factor: 53.440

6.  Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice.

Authors:  E F Verdú; P Bercik; M Verma-Gandhu; X-X Huang; P Blennerhassett; W Jackson; Y Mao; L Wang; F Rochat; S M Collins
Journal:  Gut       Date:  2005-08-16       Impact factor: 23.059

7.  Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.

Authors:  E A Williams; J Stimpson; D Wang; S Plummer; I Garaiova; M E Barker; B M Corfe
Journal:  Aliment Pharmacol Ther       Date:  2008-09-09       Impact factor: 8.171

Review 8.  Opioid receptors in the gastrointestinal tract.

Authors:  Peter Holzer
Journal:  Regul Pept       Date:  2009-04-02

Review 9.  Therapeutic impact of toll-like receptors on inflammatory bowel diseases: a multiple-edged sword.

Authors:  Elke Cario
Journal:  Inflamm Bowel Dis       Date:  2008-03       Impact factor: 5.325

10.  Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting.

Authors:  Jutta Zwielehner; Cornelia Lassl; Berit Hippe; Angelika Pointner; Olivier J Switzeny; Marlene Remely; Elvira Kitzweger; Reinhard Ruckser; Alexander G Haslberger
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

View more
  6 in total

1.  Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice.

Authors:  M Aguilera; M Cerdà-Cuéllar; V Martínez
Journal:  Gut Microbes       Date:  2015-01-20

Review 2.  Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis.

Authors:  Carlos Magno da Costa Maranduba; Sandra Bertelli Ribeiro De Castro; Gustavo Torres de Souza; Cristiano Rossato; Francisco Carlos da Guia; Maria Anete Santana Valente; João Vitor Paes Rettore; Claudinéia Pereira Maranduba; Camila Maurmann de Souza; Antônio Márcio Resende do Carmo; Gilson Costa Macedo; Fernando de Sá Silva
Journal:  J Immunol Res       Date:  2015-02-22       Impact factor: 4.818

3.  Lipopolysaccharides facilitate colonic motor alterations associated to the sensitization to a luminal antigen in rats.

Authors:  Ferran Jardi; Monica Aguilera; Patri Vergara; Vicente Martinez
Journal:  J Neurogastroenterol Motil       Date:  2015-03-30       Impact factor: 4.924

Review 4.  Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease.

Authors:  Claudio Bernardazzi; Beatriz Pêgo; Heitor Siffert P de Souza
Journal:  Mediators Inflamm       Date:  2016-07-04       Impact factor: 4.711

5.  Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease.

Authors:  Elena Barengolts; Stefan J Green; Yuval Eisenberg; Arfana Akbar; Bharathi Reddivari; Brian T Layden; Lara Dugas; George Chlipala
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

Review 6.  Gastrointestinal disorders associated with migraine: A comprehensive review.

Authors:  Carlos R Cámara-Lemarroy; Rene Rodriguez-Gutierrez; Roberto Monreal-Robles; Alejandro Marfil-Rivera
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.